SCHEMBL7793390

SCHEMBL7793390

O=C(NC(CSSCC(NC(=O)c1ccccc1)C(=O)NCCc1ccccc1)C(=O)NCCc1ccccc1)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.57
CTSL P07711 2/20 0.52
CTSS P25774 1/20 0.52
CTSK P43235 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
ALDH1A1 P00352 1/20 0.51
ALOX12 P18054 1/20 0.51
RAB9A P51151 5/20 0.50
NPC1 O15118 4/20 0.50
HDAC2 Q92769 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
ESRRG P62508 1/20 0.50
HPGD P15428 1/20 0.49
GRIN1 Q05586 2/20 0.48
GRIN2A Q12879 2/20 0.48
CA12 O43570 1/20 0.48
CA2 P00918 1/20 0.48
CA9 Q16790 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7799255 0.91 L3MBTL1 (0.50) KMT2ACTSLL3MBTL1RAB9ANPC1
SCHEMBL7798889 0.91 NPC1 (0.64) KMT2ACTSLCTSSCTSKL3MBTL1
SCHEMBL7798884 0.88 ALDH1A1 (0.58) KMT2ACTSLCTSSCTSKL3MBTL1
SCHEMBL7793435 0.85 CA12 (0.52) KMT2ACTSSCTSKALDH1A1HPGD
SCHEMBL7799262 0.83 POLB (0.52) KMT2ACA12CA2CA9
SCHEMBL10073683 0.82 CTSL (0.49) KMT2ACTSLCTSSCTSKALDH1A1
SCHEMBL7798914 0.80 POLB (0.48) KMT2AALDH1A1RAB9ANPC1HPGD
SCHEMBL7793398 0.79 L3MBTL1 (0.46) KMT2ACTSLCTSSCTSKL3MBTL1
SCHEMBL7793454 0.79 MMP1 (0.64) KMT2AALDH1A1HDAC2HDAC8HDAC6
SCHEMBL7793447 0.79 MMP1 (0.64) KMT2AALDH1A1HDAC2HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1143960-A2 CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES Roche Diagnostics GmbH (DE) 2001-10-17 EP disclosed
WO-2000027378-A2 CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES ROCHE DIAGNOSTICS GMBH (DE) 2000-05-18 WO disclosed